Home › B-Cell Lymphoma › Missouri › St. Louis
B-Cell Lymphoma clinical trials in St. Louis, MO
5 studies for B-Cell Lymphoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RecruitingPhase 3
- Washington University School of Medicine, St Louis
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
RecruitingPhase 1
- Washington University School of Medicine/Siteman Cancer Center, St Louis
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RecruitingPhase 1/2
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Washington University, St. Louis, St Louis
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
RecruitingPhase 1/2
- Washington University, St Louis
B-Cell Lymphoma trials in other cities
- New York City, NY17 studies
- Houston, TX16 studies
- Chicago, IL13 studies
- Nashville, TN12 studies
- Philadelphia, PA11 studies
- Rochester, MN10 studies
- Milwaukee, WI10 studies
- Boston, MA10 studies
- Baldwin Park, CA9 studies
- Cleveland, OH8 studies
- Salt Lake City, UT8 studies
- Seattle, WA8 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.